In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 |
| 10-K | 10-K | 10-K/A |
Revenues [+] | 330.6 | 164.1 | 79.4 |
Net interest income | | | 4.3 |
Other income | | | 0.2 |
Revenue growth | 101.5% | 106.6% | |
Cost of goods sold | 0.0 | 0.0 | 0.0 |
Gross profit | 330.6 | 164.1 | 79.4 |
Gross margin | 100.0% | 100.0% | 100.0% |
Selling, general and administrative [+] | 439.4 | 244.4 | 20.7 |
Sales and marketing | | | 11.1 |
General and administrative [+] | | | 8.4 |
General and administrative expenses | | | 8.4 |
Professional fees | | | 8.4 |
Other selling, general and administrative | | | 1.2 |
Other operating expenses | 115.5 | 41.1 | 19.1 |
EBITDA [+] | -202.6 | -119.1 | 39.6 |
EBITDA growth | 70.1% | -400.8% | |
EBITDA margin | -61.3% | -72.6% | 49.9% |
Depreciation | 1.2 | 0.3 | 1.1 |
EBITA | -203.8 | -119.4 | 38.5 |
EBITA margin | -61.7% | -72.8% | 48.5% |
Amortization of intangibles | 20.4 | 2.0 | |
EBIT [+] | -224.3 | -121.5 | 38.5 |
EBIT growth | 84.6% | -415.7% | |
EBIT margin | -67.8% | -74.0% | 48.5% |
Non-recurring items | -1.7 | 8.3 | |
Interest expense | | | 3.0 |
Interest expense | 29.8 | 7.3 | 3.0 |
Other income (expense), net [+] | 37.7 | -32.4 | -14.2 |
Gain (loss) on derivative instruments | | | 4.0 |
Unrealized gain/loss on derivatives | -7.9 | 39.6 | 14.4 |
Gain (loss) on foreign currency transactions | | | -0.2 |
Change in fair value of warrants | -7.9 | 39.6 | 14.4 |
Pre-tax income | -214.7 | -169.4 | 21.3 |
Income taxes | -25.6 | 0.1 | 0.0 |
Tax rate | 11.9% | | 0.0% |
Net income | -189.1 | -182.3 | -67.2 |
Net margin | -57.2% | -111.1% | -84.6% |
|
Basic EPS [+] | ($0.78) | ($1.88) | ($1.49) |
Growth | -58.3% | 26.1% | |
Diluted EPS [+] | ($0.78) | ($1.88) | ($1.49) |
Growth | -58.3% | 26.1% | |
|
Shares outstanding (basic) [+] | 241.7 | 97.2 | 45.2 |
Growth | 148.8% | 115.1% | |
Shares outstanding (diluted) [+] | 241.7 | 97.2 | 45.2 |
Growth | 148.8% | 115.1% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |